White Matter Abnormalities and Animal Models Examining a Putative Role of Altered White Matter in Schizophrenia
Authors:
Open Access
- 11 August 2011
- journal article
- review article
- Published by Hindawi Limited in Schizophrenia Research and Treatment
- Vol. 2011, 1-16
Abstract
Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide. Although the dopamine (DA) hypothesis is still keeping a dominant position in schizophrenia research, new advances have been emerging in recent years, which suggest the implication of white matter abnormalities in schizophrenia. In this paper, we will briefly review some of recent human studies showing white matter abnormalities in schizophrenic brains and altered oligodendrocyte-(OL-) and myelin-related genes in patients with schizophrenia and will consider abnormal behaviors reported in patients with white matter diseases. Following these, we will selectively introduce some animal models examining a putative role of white matter abnormalities in schizophrenia. The emphasis will be put on the cuprizone (CPZ) model. CPZ-fed mice show demyelination and OLs loss, display schizophrenia-related behaviors, and have higher DA levels in the prefrontal cortex. These features suggest that the CPZ model is a novel animal model of schizophrenia.Keywords
This publication has 153 references indexed in Scilit:
- Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophreniaProgress in Neurobiology, 2011
- White matter volume abnormalities and associations with symptomatology in schizophreniaPsychiatry Research: Neuroimaging, 2010
- Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in ratsSchizophrenia Research, 2009
- Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1 -null miceProceedings of the National Academy of Sciences, 2008
- Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophreniaSchizophrenia Research, 2008
- Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disordersProceedings of the National Academy of Sciences, 2007
- Convergent evidence that oligodendrocyte lineage transcription factor 2 ( OLIG2 ) and interacting genes influence susceptibility to schizophreniaProceedings of the National Academy of Sciences, 2006
- Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophreniaProceedings of the National Academy of Sciences, 2006
- A family-based association study of PLP1 and schizophreniaNeuroscience Letters, 2005
- Cognitive dysfunction in multiple sclerosis.Neurology, 1991